{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:44:26Z","timestamp":1780386266939,"version":"3.54.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schizophr"],"DOI":"10.1038\/s41537-025-00694-y","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:05:50Z","timestamp":1765886750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between metabolic syndrome, diabetes mellitus, inflammation and cognitive dysfunctions in schizophrenia: a cross-sectional analysis"],"prefix":"10.1038","volume":"11","author":[{"given":"Alexander","family":"Kancsev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Anne","family":"Engh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s Attila","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Hegyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oguz","family":"Kelemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szabolcs","family":"K\u00e9ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"694_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.67","volume":"1","author":"RS Kahn","year":"2015","unstructured":"Kahn, R. S. et al. Schizophrenia. Nat. Rev. Dis. Prim. 1, 15067 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"694_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/schbul\/sbab033","volume":"47","author":"M Cowman","year":"2021","unstructured":"Cowman, M. et al. Cognitive predictors of social and occupational functioning in early psychosis: a systematic review and meta-analysis of cross-sectional and longitudinal data. Schizophr. Bull. 47, 1243\u20131253 (2021).","journal-title":"Schizophr. Bull."},{"key":"694_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrd3628","volume":"11","author":"MJ Millan","year":"2012","unstructured":"Millan, M. J. et al. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat. Rev. Drug Discov. 11, 141\u2013168 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"694_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/wps.20252","volume":"14","author":"D Vancampfort","year":"2015","unstructured":"Vancampfort, D. et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry 14, 339\u2013347 (2015).","journal-title":"World Psychiatry"},{"key":"694_CR5","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1017\/S0033291716003366","volume":"47","author":"E Bora","year":"2017","unstructured":"Bora, E., Akdede, B. B. & Alptekin, K. The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis. Psychol. Med. 47, 1030\u20131040 (2017).","journal-title":"Psychol. Med."},{"key":"694_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrcardio.2014.223","volume":"12","author":"C Qiu","year":"2015","unstructured":"Qiu, C. & Fratiglioni, L. A major role for cardiovascular burden in age-related cognitive decline. Nat. Rev. Cardiol. 12, 267\u2013277 (2015).","journal-title":"Nat. Rev. Cardiol."},{"key":"694_CR7","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1001\/jamapsychiatry.2019.4188","volume":"77","author":"S Bahrami","year":"2020","unstructured":"Bahrami, S. et al. Shared genetic loci between body mass index and major psychiatric disorders: a genome-wide association study. JAMA Psychiatry 77, 503\u2013512 (2020).","journal-title":"JAMA Psychiatry"},{"key":"694_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.114947","volume":"318","author":"H Lv","year":"2022","unstructured":"Lv, H. et al. Identification of genetic loci that overlap between schizophrenia and metabolic syndrome. Psychiatry Res. 318, 114947 (2022).","journal-title":"Psychiatry Res."},{"key":"694_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0304-6","volume":"8","author":"S Hackinger","year":"2018","unstructured":"Hackinger, S. et al. Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophrenia. Transl. Psychiatry 8, 252 (2018).","journal-title":"Transl. Psychiatry"},{"key":"694_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.schres.2024.06.056","volume":"270","author":"A Morris","year":"2024","unstructured":"Morris, A., Reed, T., McBride, G. & Chen, J. Dietary interventions to improve metabolic health in schizophrenia: a systematic literature review of systematic reviews. Schizophr. Res 270, 372\u2013382 (2024).","journal-title":"Schizophr. Res"},{"key":"694_CR11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3389\/fpsyt.2019.00573","volume":"10","author":"M Druart","year":"2019","unstructured":"Druart, M. & Le Magueresse, C. Emerging roles of complement in psychiatric disorders. Front. Psychiatry 10, 573 (2019).","journal-title":"Front. Psychiatry"},{"key":"694_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/schbul\/sbx035","volume":"44","author":"AK Wang","year":"2018","unstructured":"Wang, A. K. & Miller, B. J. Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and depression. Schizophr. Bull. 44, 75\u201383 (2018).","journal-title":"Schizophr. Bull."},{"key":"694_CR13","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/schbul\/sby024","volume":"44","author":"N M\u00fcller","year":"2018","unstructured":"M\u00fcller, N. Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations. Schizophr. Bull. 44, 973\u2013982 (2018).","journal-title":"Schizophr. Bull."},{"key":"694_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41418-022-01062-4","volume":"30","author":"X Hildebrandt","year":"2023","unstructured":"Hildebrandt, X., Ibrahim, M. & Peltzer, N. Cell death and inflammation during obesity: \u2018Know my methods, WAT(son). Cell Death Differ. 30, 279\u2013292 (2023).","journal-title":"Cell Death Differ."},{"key":"694_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110097","volume":"106","author":"C Zeng","year":"2021","unstructured":"Zeng, C. et al. Gut microbiota: An intermediary between metabolic syndrome and cognitive deficits in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 106, 110097 (2021).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"694_CR16","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1038\/s41380-024-02503-x","volume":"29","author":"K Allott","year":"2024","unstructured":"Allott, K., Chopra, S., Rogers, J., Dauvermann, M. R. & Clark, S. R. Advancing understanding of the mechanisms of antipsychotic-associated cognitive impairment to minimise harm: a call to action. Mol. Psychiatry 29, 2571\u20132574 (2024).","journal-title":"Mol. Psychiatry"},{"key":"694_CR17","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3389\/fpsyt.2018.00622","volume":"9","author":"NE MacKenzie","year":"2018","unstructured":"MacKenzie, N. E. et al. Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia. Front. Psychiatry 9, 622 (2018).","journal-title":"Front. Psychiatry"},{"key":"694_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jamapsychiatry.2016.3803","volume":"74","author":"T Pillinger","year":"2017","unstructured":"Pillinger, T. et al. Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis. JAMA Psychiatry 74, 261\u2013269 (2017).","journal-title":"JAMA Psychiatry"},{"key":"694_CR19","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (DSM-5), 5th ed., 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"694_CR20","unstructured":"First, M. B., Williams, J. B. W., Karg, R. S. & Spitzer, R. L. Structured Clinical Interview for DSM-5 Disorders\u2014Clinician Version (SCID-5-CV) (American Psychiatric Association Publishing, 2016)."},{"key":"694_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay, S. R., Fiszbein, A. & Opler, L. A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 13, 261\u2013276 (1987).","journal-title":"Schizophr. Bull."},{"key":"694_CR22","doi-asserted-by":"crossref","unstructured":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285, 2486\u20132497 (2001).","DOI":"10.1001\/jama.285.19.2486"},{"key":"694_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1076\/jcen.20.3.310.823","volume":"20","author":"C Randolph","year":"1998","unstructured":"Randolph, C., Tierney, M. C., Mohr, E. & Chase, T. N. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J. Clin. Exp. Neuropsychol. 20, 310\u2013319 (1998).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"694_CR24","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1001\/jamapsychiatry.2021.0015","volume":"78","author":"K Hagi","year":"2021","unstructured":"Hagi, K. et al. Association between cardiovascular risk factors and cognitive impairment in people with schizophrenia: a systematic review and meta-analysis. JAMA Psychiatry 78, 510\u2013518 (2021).","journal-title":"JAMA Psychiatry"},{"key":"694_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","volume":"7","author":"M Li","year":"2022","unstructured":"Li, M. et al. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct. Target Ther. 7, 216 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"694_CR26","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00032.2015","volume":"96","author":"S Kullmann","year":"2016","unstructured":"Kullmann, S. et al. Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans. Physiol. Rev. 96, 1169\u20131209 (2016).","journal-title":"Physiol. Rev."},{"key":"694_CR27","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1073\/pnas.1500877112","volume":"112","author":"A Kleinridders","year":"2015","unstructured":"Kleinridders, A. et al. Insulin resistance in brain alters dopamine turnover and causes behavioral disorders. Proc. Natl. Acad. Sci. USA 112, 3463\u20133468 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"694_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold, S. E. et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat. Rev. Neurol. 14, 168\u2013181 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"694_CR29","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S2213-8587(20)30113-3","volume":"8","author":"S Kullmann","year":"2020","unstructured":"Kullmann, S. et al. Central nervous pathways of insulin action in the control of metabolism and food intake. Lancet Diab. Endocrinol. 8, 524\u2013534 (2020).","journal-title":"Lancet Diab. Endocrinol."},{"key":"694_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuroscience.2019.05.033","volume":"411","author":"F Zhao","year":"2019","unstructured":"Zhao, F., Siu, J. J., Huang, W., Askwith, C. & Cao, L. Insulin modulates excitatory synaptic transmission and synaptic plasticity in the mouse hippocampus. Neuroscience 411, 237\u2013254 (2019).","journal-title":"Neuroscience"},{"key":"694_CR31","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1073\/pnas.051634698","volume":"98","author":"VA Skeberdis","year":"2001","unstructured":"Skeberdis, V. A., Lan, J., Zheng, X., Zukin, R. S. & Bennett, M. V. Insulin promotes rapid delivery of N-methyl-D- aspartate receptors to the cell surface by exocytosis. Proc. Natl. Acad. Sci. USA 98, 3561\u20133566 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"694_CR32","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1038\/s41380-023-02065-4","volume":"28","author":"A de Bartolomeis","year":"2023","unstructured":"de Bartolomeis, A. et al. Insulin effects on core neurotransmitter pathways involved in schizophrenia neurobiology: a meta-analysis of preclinical studies. Implications for the treatment. Mol. Psychiatry 28, 2811\u20132825 (2023).","journal-title":"Mol. Psychiatry"},{"key":"694_CR33","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","volume":"28","author":"RA McCutcheon","year":"2023","unstructured":"McCutcheon, R. A., Keefe, R. S. E. & McGuire, P. K. Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. Mol. Psychiatry 28, 1902\u20131918 (2023).","journal-title":"Mol. Psychiatry"},{"key":"694_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/719076","volume":"2015","author":"W Xia","year":"2015","unstructured":"Xia, W. et al. Insulin resistance-associated interhemispheric functional connectivity alterations in T2DM: a resting-state fMRI study. Biomed. Res. Int. 2015, 719076 (2015).","journal-title":"Biomed. Res. Int."},{"key":"694_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s44324-024-00019-0","volume":"2","author":"HA Deery","year":"2024","unstructured":"Deery, H. A. et al. Peripheral insulin resistance attenuates cerebral glucose metabolism and impairs working memory in healthy adults. npj Metab. Health Dis. 2, 17 (2024).","journal-title":"npj Metab. Health Dis."},{"key":"694_CR36","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/jne.12254","volume":"27","author":"S Kullmann","year":"2015","unstructured":"Kullmann, S., Heni, M., Fritsche, A. & Preissl, H. Insulin action in the human brain: evidence from neuroimaging studies. J. Neuroendocrinol. 27, 419\u2013423 (2015).","journal-title":"J. Neuroendocrinol."},{"key":"694_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01907-w","volume":"7","author":"S Kullmann","year":"2017","unstructured":"Kullmann, S. et al. Intranasal insulin enhances brain functional connectivity mediating the relationship between adiposity and subjective feeling of hunger. Sci. Rep. 7, 1627 (2017).","journal-title":"Sci. Rep."},{"key":"694_CR38","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen, M. C. & Shulman, G. I. Mechanisms of insulin action and insulin resistance. Physiol. Rev. 98, 2133\u20132223 (2018).","journal-title":"Physiol. Rev."},{"key":"694_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41537-024-00475-z","volume":"10","author":"R-L Armio","year":"2024","unstructured":"Armio, R.-L. et al. Longitudinal study on hippocampal subfields and glucose metabolism in early psychosis. Schizophrenia 10, 66 (2024).","journal-title":"Schizophrenia"},{"key":"694_CR40","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.neubiorev.2013.03.010","volume":"37","author":"N Ho","year":"2013","unstructured":"Ho, N., Sommers, M. S. & Lucki, I. Effects of diabetes on hippocampal neurogenesis: links to cognition and depression. Neurosci. Biobehav. Rev. 37, 1346\u20131362 (2013).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"694_CR41","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nn2055","volume":"11","author":"AM Stranahan","year":"2008","unstructured":"Stranahan, A. M. et al. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat. Neurosci. 11, 309\u2013317 (2008).","journal-title":"Nat. Neurosci."},{"key":"694_CR42","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-021-03811-w","volume":"597","author":"D Tingley","year":"2021","unstructured":"Tingley, D., McClain, K., Kaya, E., Carpenter, J. & Buzs\u00e1ki, G. A metabolic function of the hippocampal sharp wave-ripple. Nature 597, 82\u201386 (2021).","journal-title":"Nature"},{"key":"694_CR43","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1017\/S003329172200174X","volume":"53","author":"L Townsend","year":"2023","unstructured":"Townsend, L. et al. Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia. Psychol. Med. 53, 4880\u20134897 (2023).","journal-title":"Psychol. Med."},{"key":"694_CR44","doi-asserted-by":"publisher","unstructured":"Chouinard, V.-A. et al. Cognitive Impairment in Psychotic Disorders Is Associated with Brain Reductive Stress and Impaired Energy Metabolism as Measured by 31P Magnetic Resonance Spectroscopy. Schizophr. Bull sbaf003, https:\/\/doi.org\/10.1093\/schbul\/sbaf003 (2025).","DOI":"10.1093\/schbul\/sbaf003"},{"key":"694_CR45","first-page":"125","volume":"2","author":"S Prasad","year":"2014","unstructured":"Prasad, S., Sajja, R. K., Naik, P. & Cucullo, L. Diabetes mellitus and blood-brain barrier dysfunction: an overview. J. Pharmacovigil. 2, 125 (2014).","journal-title":"J. Pharmacovigil."},{"key":"694_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41387-022-00214-2","volume":"12","author":"T Ma","year":"2022","unstructured":"Ma, T. et al. Gray and white matter abnormality in patients with T2DM-related cognitive dysfunction: a systemic review and meta-analysis. Nutr. Diab. 12, 39 (2022).","journal-title":"Nutr. Diab."},{"key":"694_CR47","doi-asserted-by":"publisher","first-page":"781","DOI":"10.4093\/dmj.2021.0189","volume":"46","author":"T Zhang","year":"2022","unstructured":"Zhang, T., Shaw, M. & Cherbuin, N. Association between type 2 diabetes mellitus and brain atrophy: a meta-analysis. Diab. Metab. J. 46, 781\u2013802 (2022).","journal-title":"Diab. Metab. J."},{"key":"694_CR48","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1161\/ATVBAHA.112.252759","volume":"32","author":"KF Yates","year":"2012","unstructured":"Yates, K. F., Sweat, V., Yau, P. L., Turchiano, M. M. & Convit, A. Impact of metabolic syndrome on cognition and brain: a selected review of the literature. Arterioscler Thromb. Vasc. Biol. 32, 2060\u20132067 (2012).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"694_CR49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cca.2019.06.019","volume":"496","author":"P Reddy","year":"2019","unstructured":"Reddy, P., Lent-Schochet, D., Ramakrishnan, N., McLaughlin, M. & Jialal, I. Metabolic syndrome is an inflammatory disorder: a conspiracy between adipose tissue and phagocytes. Clin. Chim. Acta. 496, 35\u201344 (2019).","journal-title":"Clin. Chim. Acta."},{"key":"694_CR50","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1172\/JCI96139","volume":"128","author":"M Shimobayashi","year":"2018","unstructured":"Shimobayashi, M. et al. Insulin resistance causes inflammation in adipose tissue. J. Clin. Investig. 128, 1538\u20131550 (2018).","journal-title":"J. Clin. Investig."},{"key":"694_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01349-z","volume":"11","author":"NM Lyra E Silva","year":"2021","unstructured":"Lyra E Silva, N. M. et al. Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer\u2019s disease. Transl. Psychiatry 11, 251 (2021).","journal-title":"Transl. Psychiatry"},{"key":"694_CR52","doi-asserted-by":"publisher","first-page":"42394","DOI":"10.1074\/jbc.C200444200","volume":"277","author":"L Rui","year":"2002","unstructured":"Rui, L., Yuan, M., Frantz, D., Shoelson, S. & White, M. F. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277, 42394\u201342398 (2002).","journal-title":"J. Biol. Chem."},{"key":"694_CR53","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2337\/db12-0443","volume":"62","author":"SB Jorgensen","year":"2013","unstructured":"Jorgensen, S. B. et al. Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity. Diabetes 62, 56\u201364 (2013).","journal-title":"Diabetes"},{"key":"694_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2024.105848","volume":"165","author":"Y Tian","year":"2024","unstructured":"Tian, Y., Jing, G., Ma, M., Yin, R. & Zhang, M. Microglial activation and polarization in type 2 diabetes-related cognitive impairment: a focused review of pathogenesis. Neurosci. Biobehav. Rev. 165, 105848 (2024).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"694_CR55","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2174\/1567205014666170117104053","volume":"14","author":"M Bahniwal","year":"2017","unstructured":"Bahniwal, M., Little, J. P. & Klegeris, A. High glucose enhances neurotoxicity and inflammatory cytokine secretion by stimulated human astrocytes. Curr. Alzheimer Res. 14, 731\u2013741 (2017).","journal-title":"Curr. Alzheimer Res."},{"key":"694_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2022.110668","volume":"121","author":"SR Patlola","year":"2023","unstructured":"Patlola, S. R., Donohoe, G. & McKernan, D. P. The relationship between inflammatory biomarkers and cognitive dysfunction in patients with schizophrenia: A systematic review and meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry 121, 110668 (2023).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"694_CR57","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1038\/s41380-024-02539-z","volume":"29","author":"S Chen","year":"2024","unstructured":"Chen, S., Tan, Y. & Tian, L. Immunophenotypes in psychosis: is it a premature inflamm-aging disorder? Mol. Psychiatry 29, 2834\u20132848 (2024).","journal-title":"Mol. Psychiatry"},{"key":"694_CR58","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.bbi.2016.12.011","volume":"62","author":"S K\u00e9ri","year":"2017","unstructured":"K\u00e9ri, S., Szab\u00f3, C. & Kelemen, O. Antipsychotics influence Toll-like receptor (TLR) expression and its relationship with cognitive functions in schizophrenia. Brain Behav. Immun. 62, 256\u2013264 (2017).","journal-title":"Brain Behav. Immun."},{"key":"694_CR59","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41582-019-0174-4","volume":"15","author":"K Pape","year":"2019","unstructured":"Pape, K., Tamouza, R., Leboyer, M. & Zipp, F. Immunoneuropsychiatry - novel perspectives on brain disorders. Nat. Rev. Neurol. 15, 317\u2013328 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"694_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.238","volume":"6","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation. Transl. Psychiatry 6, e982 (2016).","journal-title":"Transl. Psychiatry"},{"key":"694_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1356975","volume":"15","author":"C Chaves","year":"2024","unstructured":"Chaves, C., Dursun, S. M., Tusconi, M. & Hallak, J. E. C. Neuroinflammation and schizophrenia - is there a link? Front. Psychiatry 15, 1356975 (2024).","journal-title":"Front. Psychiatry"},{"key":"694_CR62","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/s41380-022-01798-y","volume":"27","author":"LN Castellani","year":"2022","unstructured":"Castellani, L. N. et al. Antipsychotics impair regulation of glucose metabolism by central glucose. Mol. Psychiatry 27, 4741\u20134753 (2022).","journal-title":"Mol. Psychiatry"},{"key":"694_CR63","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","volume":"7","author":"T Pillinger","year":"2020","unstructured":"Pillinger, T. et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry 7, 64\u201377 (2020).","journal-title":"Lancet Psychiatry"},{"key":"694_CR64","doi-asserted-by":"publisher","first-page":"e115225","DOI":"10.1371\/journal.pone.0115225","volume":"9","author":"AP Morgan","year":"2014","unstructured":"Morgan, A. P. et al. The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse. PLoS One 9, e115225 (2014).","journal-title":"PLoS One"},{"key":"694_CR65","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/schbul\/sbv028","volume":"41","author":"V Mondelli","year":"2015","unstructured":"Mondelli, V. et al. Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis. Schizophr. Bull. 41, 1162\u20131170 (2015).","journal-title":"Schizophr. Bull."},{"key":"694_CR66","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3109\/15622975.2015.1062552","volume":"16","author":"C Noto","year":"2015","unstructured":"Noto, C. et al. High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance. World J. Biol. Psychiatry 16, 422\u2013429 (2015).","journal-title":"World J. Biol. Psychiatry"},{"key":"694_CR67","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1001\/jamapsychiatry.2019.0304","volume":"76","author":"J Tomasik","year":"2019","unstructured":"Tomasik, J. et al. Association of insulin resistance with schizophrenia polygenic risk score and response to antipsychotic treatment. JAMA Psychiatry 76, 864\u2013867 (2019).","journal-title":"JAMA Psychiatry"},{"key":"694_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1593341","volume":"16","author":"VA Pavlov","year":"2025","unstructured":"Pavlov, V. A. Novel opportunities for treating complex neuropsychiatric and neurocognitive conditions based on recent developments with xanomeline. Front Psychiatry 16, 1593341 (2025).","journal-title":"Front Psychiatry"},{"key":"694_CR69","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41537-024-00472-2","volume":"10","author":"CN Metz","year":"2024","unstructured":"Metz, C. N., Brines, M. & Pavlov, V. A. Bridging cholinergic signalling and inflammation in schizophrenia. Schizophr 10, 51 (2024).","journal-title":"Schizophr"},{"key":"694_CR70","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/s41591-021-01458-8","volume":"27","author":"P Hegyi","year":"2021","unstructured":"Hegyi, P., Er\u0151ss, B., Izb\u00e9ki, F., P\u00e1rniczky, A. & Szentesi, A. Accelerating the translational medicine cycle: the Academia Europaea pilot. Nat. Med 27, 1317\u20131319 (2021).","journal-title":"Nat. Med"},{"key":"694_CR71","doi-asserted-by":"publisher","unstructured":"Hegyi, P. et al. Academia Europaea position paper on translational medicine: the cycle model for translating scientific results into community benefits. J. Clin. Med. 9, https:\/\/doi.org\/10.3390\/jcm9051532 (2020).","DOI":"10.3390\/jcm9051532"},{"key":"694_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.115866","volume":"335","author":"S Sethi","year":"2024","unstructured":"Sethi, S. et al. Ketogenic diet intervention on metabolic and psychiatric health in bipolar and schizophrenia: a pilot trial. Psychiatry Res. 335, 115866 (2024).","journal-title":"Psychiatry Res."},{"key":"694_CR73","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1176\/appi.ajp.2017.17060716","volume":"175","author":"DL Noordsy","year":"2018","unstructured":"Noordsy, D. L., Burgess, J. D., Hardy, K. V., Yudofsky, L. M. & Ballon, J. S. Therapeutic potential of physical exercise in early psychosis. Am. J. Psychiatry 175, 209\u2013214 (2018).","journal-title":"Am. J. Psychiatry"}],"container-title":["Schizophrenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00694-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00694-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00694-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:03:15Z","timestamp":1765929795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00694-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["694"],"URL":"https:\/\/doi.org\/10.1038\/s41537-025-00694-y","relation":{},"ISSN":["2754-6993"],"issn-type":[{"value":"2754-6993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}